John S. McBride - 01 May 2023 Form 4 Insider Report for Eledon Pharmaceuticals, Inc. (ELDN)

Role
Director
Signature
/s/ John McBride
Issuer symbol
ELDN
Transactions as of
01 May 2023
Net transactions value
$0
Form type
4
Filing time
02 May 2023, 18:44:49 UTC
Previous filing
02 Feb 2023
Next filing
13 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELDN Stock Option (right to buy) Award $0 +150,437 $0.000000 150,437 01 May 2023 Common Stock 150,437 $2.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase up to 150,437 shares of Common Stock, which option vests with respect to 75,219 shares on May 1, 2024 and with respect to 75,218 shares on May 1, 2025.